PureTech Health (UK) Today
| PRTC Stock | 129.20 2.20 1.67% |
PerformanceVery Weak
| Odds Of DistressLow
|
PureTech Health is selling for under 129.20 as of the 22nd of March 2025; that is 1.67 percent decrease since the beginning of the trading day. The stock's lowest day price was 128.8. PureTech Health has about a 25 % chance of experiencing some form of financial distress in the next two years of operation but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 22nd of December 2024 and ending today, the 22nd of March 2025. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | Category Healthcare | Classification Health Care |
PureTech Health is entity of United Kingdom. It is traded as Stock on LSE exchange. The company has 240.19 M outstanding shares. More on PureTech Health plc
Moving against PureTech Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
PureTech Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. PureTech Health's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding PureTech Health or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CoFounder President | Eric Elenko | ||||
| Thematic Ideas | (View all Themes) | ||||
| Business Concentration | Life Sciences Tools & Services, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Health Management, IT, Management, Health Care, Life Sciences Tools & Services, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Computing (View all Sectors) | ||||
PureTech Health's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to PureTech Health's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | |||||
Debt LevelsPureTech Health can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand PureTech Health's financial leverage. It provides some insight into what part of PureTech Health's total assets is financed by creditors.
| |||||
PureTech Health plc (PRTC) is traded on London Exchange in UK and employs 90 people. PureTech Health is listed under Life Sciences Tools & Services category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 311.74 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate PureTech Health's market, we take the total number of its shares issued and multiply it by PureTech Health's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. PureTech Health plc operates under Life Sciences Tools & Services sector and is part of Health Care industry. The entity has 240.19 M outstanding shares.
PureTech Health generates negative cash flow from operations
Check PureTech Health Probability Of Bankruptcy
Ownership AllocationPureTech Health owns a total of 240.19 Million outstanding shares. The majority of PureTech Health plc outstanding shares are owned by third-party entities. These institutional holders are usually referred to as non-private investors looking to secure positions in PureTech Health plc to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in PureTech Health. Please pay attention to any change in the institutional holdings of PureTech Health plc as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check PureTech Ownership Details
PureTech Health plc Risk Profiles
Although PureTech Health's alpha and beta are two of the key measurements used to evaluate PureTech Health's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.43 | |||
| Standard Deviation | 1.81 | |||
| Variance | 3.27 | |||
| Risk Adjusted Performance | (0.15) |
PureTech Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in PureTech Health without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Competition Analyzer Now
Competition AnalyzerAnalyze and compare many basic indicators for a group of related or unrelated entities |
| All Next | Launch Module |
PureTech Health Corporate Management
Elected by the shareholders, the PureTech Health's board of directors comprises two types of representatives: PureTech Health inside directors who are chosen from within the company, and outside directors, selected externally and held independent of PureTech. The board's role is to monitor PureTech Health's management team and ensure that shareholders' interests are well served. PureTech Health's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, PureTech Health's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Anita JD | Senior Property | Profile | |
| Lauren MBA | Chief Officer | Profile | |
| Spencer Ball | Senior Resources | Profile | |
| III JD | General Secretary | Profile | |
| Joseph Bolen | Chief Officer | Profile |
Additional Tools for PureTech Stock Analysis
When running PureTech Health's price analysis, check to measure PureTech Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PureTech Health is operating at the current time. Most of PureTech Health's value examination focuses on studying past and present price action to predict the probability of PureTech Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PureTech Health's price. Additionally, you may evaluate how the addition of PureTech Health to your portfolios can decrease your overall portfolio volatility.